Kidney Biopsy Should Be Performed to Document the Cause of Immune Checkpoint Inhibitor–Associated Acute Kidney Injury: PRO
Authors:
Open Access
- 26 March 2020
- journal article
- editorial
- Published by Wolters Kluwer Health in Kidney360
- Vol. 1 (3) , 158-161
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- The Incidence, Causes, and Risk Factors of Acute Kidney Injury in Patients Receiving Immune Checkpoint InhibitorsClinical Journal of the American Society of Nephrology, 2019
- Urine TNF-α and IL-9 for clinical diagnosis of acute interstitial nephritisJCI Insight, 2019
- AKI in Patients Receiving Immune Checkpoint InhibitorsClinical Journal of the American Society of Nephrology, 2019
- Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice GuidelineJournal of Clinical Oncology, 2018
- Longitudinal study of short‐term corticosteroid use by working‐age adults with diabetes mellitus: Risks and mitigating factorsJournal of Diabetes, 2017
- Acute Kidney Injury in Patients with CancerNew England Journal of Medicine, 2017
- Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort studyBMJ, 2017
- Adverse Renal Effects of Immune Checkpoint Inhibitors: A Narrative ReviewAmerican Journal of Nephrology, 2017
- Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsKidney International, 2016
- Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer PatientsAmerican Journal of Kidney Diseases, 2016